Bridgeway Capital Management’s Blonder Tongue Laboratories Inc BDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-90,000
| Closed | -$58K | – | 1408 |
|
|
2022
Q1 | $58K | Hold |
90,000
| – | – | ﹤0.01% | 1284 |
|
|
2021
Q4 | $53K | Hold |
90,000
| – | – | ﹤0.01% | 1243 |
|
|
2021
Q3 | $103K | Hold |
90,000
| – | – | ﹤0.01% | 1250 |
|
|
2021
Q2 | $119K | Buy |
90,000
+50,000
| +125% | +$61.4K | ﹤0.01% | 1305 |
|
|
2021
Q1 | $59K | Sell |
40,000
-270,100
| -87% | -$424K | ﹤0.01% | 1343 |
|
|
2020
Q4 | $412K | Hold |
310,100
| – | – | 0.01% | 1019 |
|
|
2020
Q3 | $254K | Hold |
310,100
| – | – | 0.01% | 1126 |
|
|
2020
Q2 | $223K | Hold |
310,100
| – | – | ﹤0.01% | 1122 |
|
|
2020
Q1 | $196K | Hold |
310,100
| – | – | ﹤0.01% | 1066 |
|
|
2019
Q4 | $236K | Hold |
310,100
| – | – | ﹤0.01% | 1171 |
|
|
2019
Q3 | $205K | Hold |
310,100
| – | – | ﹤0.01% | 1176 |
|
|
2019
Q2 | $301K | Hold |
310,100
| – | – | ﹤0.01% | 1098 |
|
|
2019
Q1 | $338K | Hold |
310,100
| – | – | ﹤0.01% | 1128 |
|
|
2018
Q4 | $343K | Hold |
310,100
| – | – | ﹤0.01% | 1103 |
|
|
2018
Q3 | $388K | Buy |
310,100
+152,600
| +97% | +$197K | ﹤0.01% | 1197 |
|
|
2018
Q2 | $178K | Buy |
+157,500
| New | +$168K | ﹤0.01% | 1314 |
|
|
2017
Q1 | – | Sell |
-17,859
| Closed | -$8K | – | 1493 |
|
|
2016
Q4 | $8K | Hold |
17,859
| – | – | ﹤0.01% | 1399 |
|
|
2016
Q3 | $11K | Hold |
17,859
| – | – | ﹤0.01% | 1419 |
|
|
2016
Q2 | $9K | Hold |
17,859
| – | – | ﹤0.01% | 1425 |
|
|
2016
Q1 | $7K | Hold |
17,859
| – | – | ﹤0.01% | 1426 |
|
|
2015
Q4 | $7K | Hold |
17,859
| – | – | ﹤0.01% | 1424 |
|
|
2015
Q3 | $11K | Sell |
17,859
-20,000
| -53% | -$14K | ﹤0.01% | 1457 |
|
|
2015
Q2 | $29K | Hold |
37,859
| – | – | ﹤0.01% | 1480 |
|
|
2015
Q1 | $36K | Buy |
37,859
+17,859
| +89% | +$32.9K | ﹤0.01% | 1462 |
|
|
2014
Q4 | $54K | Hold |
20,000
| – | – | ﹤0.01% | 1428 |
|
|
2014
Q3 | $26K | Buy |
+20,000
| New | +$25.5K | ﹤0.01% | 1464 |
|
Bridgeway Capital Management's BDR Position: Q2 2022 in Review
Bridgeway Capital Management sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 90,000 shares — an estimated $58K sold.
Bridgeway Capital Management first reported a position in BDR in Q3 2014 and held it in 26 quarters. The position peaked at $412K in Q4 2020. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.
- Bridgeway Capital Management reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
- Bridgeway Capital Management sold 90,000 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $58K.
- Bridgeway Capital Management first reported a position in Blonder Tongue Laboratories Inc in Q3 2014 and held it in 26 quarters.
- Bridgeway Capital Management's Blonder Tongue Laboratories Inc position peaked at $412K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.
Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.